Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft

Abstract

Transcatheter aortic valve implantation (TAVI) in severe aortic stenosis has proven to be a feasible and effective treatment modality for inoperable patients. Until now, neither aortic regurgitation nor degenerated bioprostheses has been an indication for TAVI. However, this article reports a successful valve-in-valve implantation of a CoreValve aortic valve prosthesis through the right subclavian artery in a case of severe aortic regurgitation within a degenerated aortic homograft. The case exemplifies the possibilities of expanding the indications for TAVI, as well as other vascular access options than the femoral arteries.

OriginalsprogEngelsk
TidsskriftThe Journal of invasive cardiology
Vol/bind21
Udgave nummer10
Sider (fra-til)E197-200
ISSN1042-3931
StatusUdgivet - okt. 2009
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft'. Sammen danner de et unikt fingeraftryk.

Citationsformater